Krause Kevin Michael
SEC CIK 1916925 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Chief Strategy Off | 31.9K | — | $201.3K | 6 | 2024-01-02 | 2024-03-15 |
Most active insiders at ANTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Readnour Robin Shane | Dir | — | $316.7K |
| 2 | Eizen Joshua M | See Remarks | — | $52.9K |
| 3 | FitzPatrick Margaret M | Dir | $11.6K | — |
| 4 | Chanda Sanjay | Chief Development Off | — | $9,311 |
| 5 | Day Lucy | CFO | — | $8,862 |
| 6 | Prior Stephen David | Chief Strategy Off | — | $7,363 |
| 7 | Williams Sarah Joanne | Principal Accounting Off | — | $3,025 |
| 8 | Trenor Cameron C. III | Chief Medical Off | — | — |
| 9 | Marks Gilbert Lynn | Dir | — | — |
| 10 | Martin Patricia A. | Dir | — | — |
Krause Kevin Michael made no open-market trades at ANTX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-03-29 | 2024-03-15 | ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Off | A - Grant | $0.00 | +30.0K | 31.9K | +1,567% | $0 |
| D | 2024-03-18 | 2024-03-15 | ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Off | A - Grant | $0.00 | +30.0K | 31.9K | +1,567% | $0 |
| DMT | 2024-01-11 | 2024-01-09 | ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Off | M - OptEx | $4.59 | +7,417 | 9,331 | +388% | +$34.0K |
| DT | 2024-01-11 | 2024-01-09 | ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Off | S - Sale+OE | $20.14 | -7,417 | 1,914 | -79% | -$149.4K |
| DT | 2024-01-04 | 2024-01-02 | ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Off | M - OptEx | $0.42 | +2,583 | 4,497 | +135% | +$1,085 |
| DT | 2024-01-04 | 2024-01-02 | ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Off | S - Sale+OE | $20.12 | -2,583 | 1,914 | -57% | -$52.0K |
Purchase Sale Sale after option exercise All abbreviations